Literature DB >> 3107844

Oxygen radicals in brain injury.

H A Kontos, J T Povlishock.   

Abstract

Experimental fluid percussion brain injury in anesthetized cats causes vascular injury characterized by sustained arteriolar dilation, abnormal reactivity to vasoconstrictor and vasodilator interventions, focal endothelial lesions, and reduction of the oxygen consumption of the vessel wall. These abnormalities are minimized or completely inhibited by pretreatment with cyclooxygenase inhibitors or with oxygen radical scavengers. They were therefore ascribed to oxygen radicals generated in the course of accelerated arachidonate metabolism via cyclooxygenase. Following this type of brain injury, there is an increase in the activity of phospholipase c in the brain and a transient increase in brain concentration of prostaglandins. Superoxide anion radical was detected in the extracellular space of the brain both immediately following brain injury as well as one hour afterwards as the superoxide dismutase inhibitable portion of nitroblue tetrazolium reduction. The sustained dilation and abnormal reactivity of cerebral arterioles following brain injury were also reversed by superoxide dismutase and catalase applied on the brain surface 30 minutes after injury. These results suggest that treatment with oxygen radical scavengers might be effective in inhibiting or reversing some of the effects of brain injury, even though the intervention with the therapeutic agents occurs sometime after the injury has taken place.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3107844     DOI: 10.1089/cns.1986.3.257

Source DB:  PubMed          Journal:  Cent Nerv Syst Trauma        ISSN: 0737-5999


  39 in total

1.  Post-Injury Administration of Galantamine Reduces Traumatic Brain Injury Pathology and Improves Outcome.

Authors:  Jing Zhao; Michael J Hylin; Nobuhide Kobori; Kimberly N Hood; Anthony N Moore; Pramod K Dash
Journal:  J Neurotrauma       Date:  2017-12-18       Impact factor: 5.269

2.  Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury.

Authors:  X Wang; J Jung; M Asahi; W Chwang; L Russo; M A Moskowitz; C E Dixon; M E Fini; E H Lo
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

3.  The combination of either tempol or FK506 with delayed hypothermia: implications for traumatically induced microvascular and axonal protection.

Authors:  Motoki Fujita; Yasutaka Oda; Enoch P Wei; John T Povlishock
Journal:  J Neurotrauma       Date:  2011-07       Impact factor: 5.269

Review 4.  Antioxidant therapies for traumatic brain injury.

Authors:  Edward D Hall; Radhika A Vaishnav; Ayman G Mustafa
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

Review 5.  Acrolein-mediated injury in nervous system trauma and diseases.

Authors:  Riyi Shi; Todd Rickett; Wenjing Sun
Journal:  Mol Nutr Food Res       Date:  2011-08-08       Impact factor: 5.914

Review 6.  A Physiologically Based Approach to Prescribing Exercise Following a Sport-Related Concussion.

Authors:  Phillip R Worts; Scott O Burkhart; Jeong-Su Kim
Journal:  Sports Med       Date:  2019-05       Impact factor: 11.136

Review 7.  Measurements in vivo of parameters pertinent to ROS/RNS using EPR spectroscopy.

Authors:  Nadeem Khan; Harold Swartz
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 8.  Posthypothermic rewarming considerations following traumatic brain injury.

Authors:  John T Povlishock; Enoch P Wei
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

9.  Functional and Structural Improvement with a Catalytic Carbon Nano-Antioxidant in Experimental Traumatic Brain Injury Complicated by Hypotension and Resuscitation.

Authors:  Kimberly Mendoza; Paul J Derry; Leela Mathew Cherian; Robert Garcia; Lizanne Nilewski; J Clay Goodman; Lamin Mbye; Claudia S Robertson; James M Tour; Thomas A Kent
Journal:  J Neurotrauma       Date:  2019-03-13       Impact factor: 5.269

10.  Treadmill exercise protects against pentylenetetrazol-induced seizures and oxidative stress after traumatic brain injury.

Authors:  Luiz Fernando Almeida Silva; Maurício Scopel Hoffmann; Rogério da Rosa Gerbatin; Fernando da Silva Fiorin; Fernando Dobrachinski; Bibiana Castagna Mota; Angelica Terezinha Barth Wouters; Saulo Petinatti Pavarini; Félix Alexandre Antunes Soares; Michele Rechia Fighera; Luiz Fernando Freire Royes
Journal:  J Neurotrauma       Date:  2013-07-15       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.